Skip to main content

Find Clinical Trials

Clinical trial condition

HCC

Explore clinical trials studying HCC. Study availability and eligibility vary by location and protocol.

97 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

HCC trial results

Active, Not Recruiting

IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma

NCT06757881

Conditions: HCC
Locations: Zhongshan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC

NCT04251117

Conditions: HCC
Locations: Johns Hopkins Hospital Baltimore, Maryland, United States

Icahn School of Medicine at Mount Sinai New York, United States

Auckland Clinical Studies Auckland, New Zealand

View Trial Details

Active, Not Recruiting

Pembrolizumab in Hepatocellular Carcinoma

NCT03419481

Conditions: HCC
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

View Trial Details

Active, Not Recruiting

Cabozantinib in Hepatocellular Carcinoma

NCT04588051

Conditions: HCC
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

ASAN Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma

NCT07300488

Conditions: HCC
Locations: Nanjing Tianyinshan Hospital Nanjing, Jiangsu, China

View Trial Details

Active, Not Recruiting

A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence

NCT07009470

Conditions: HCC
Locations: Tongji Hospital Wuhan, Hubei, China

View Trial Details

Active, Not Recruiting

Composite Warming Strategy Reduces Intraoperative Hypothermia in Open Hepatectomy for Liver Cancer

NCT06766773

Conditions: HCC
Locations: The First People's Hospital of Neijiang Neijiang, Sichuan, China

View Trial Details